Sanbexin®:Edaravone and Dexborneol Concentrated Solution for Injection
Sanbexin®:Edaravone and Dexborneol Concentrated Solution for Injection
  • Seen : 112 View

0
Sanbexin®:Edaravone and Dexborneol Concentrated Solution for Injection

As a national class I innovative drug, Sanbexin® can improve the neurological function of patients with strokes by inhibiting the dual mechanisms of oxidative stress damage and inflammatory damage. Sanbexin® owns eight patents, with core patents authorized in the US, Japan and European countries and regions. It has received national special support for "Significant New Drug Development" and been awarded as one of “China’s Milestone Medical Achievements During the 13th Five-Year Plan Period”.

 

Saler Company Information

Company : Jiangsu Simcere Pharmaceutical Co., Ltd
Phone : 00862585566666
More Information : View
Online order registration form
No comments have been posted yet
loading
Your comment has been sent
Sanbexin®:Edaravone and Dexborneol Concentrated Solution for Injection

As a national class I innovative drug, Sanbexin® can improve the neurological function of patients with strokes by inhibiting the dual mechanisms of oxidative stress damage and inflammatory damage. Sanbexin® owns eight patents, with core patents authorized in the US, Japan and European countries and regions. It has received national special support for "Significant New Drug Development" and been awarded as one of “China’s Milestone Medical Achievements During the 13th Five-Year Plan Period”.

 

Saler Company Information

Company : Jiangsu Simcere Pharmaceutical Co., Ltd
Phone : 00862585566666
More Information : View
Online order registration form